Tanım

DNA repair drugs are used in repairing damaged DNA and for treating cancers. DNA damage can affect normal cell replicative function and impact rates of apoptosis. Alternatively, damage to genetic material can result in impaired cellular function, cell loss, or the transformation of healthy cells to cancers. The global DNA repair drugs market is poised to grow by US$ 45.5 sırasında milyar 2022-2028, CAGR'da ilerliyor 19.8% tahmin dönemi boyunca, veri ve analiz şirketi StratejiHelix'e göre.

Rapor, döneme ilişkin güncel pazar büyüklüğü verilerini sağlar 2018-2021 ve tahmin 2028 covering key market aspects like sales value for DNA repair drugs. The global DNA repair drugs market is segmented on the basis of application, ve bölge. By application, the global DNA repair drugs market has been segmented into breast cancer, ovarian cancer. The breast cancer segment was the largest contributor to the global DNA repair drugs market in 2021. coğrafi olarak, the global DNA repair drugs market is segmented into Asia Pacific, Avrupa, Kuzey Amerika, Dünyanın Geri Kalanı (RoW). According to the research, North America had the largest share in the global DNA repair drugs market.

The global DNA repair drugs market is highly competitive. Key companies profiled in the report include Abbott Laboratories, AbbVie Inc., Amgen Inc., AstraZeneca plc, Bayer AG, Eli Lilly and Company, Gilead Sciences Inc., GlaxoSmithKline plc (GSK), Johnson & Johnson, Merck KGaA, Novartis AG, Pfizer Inc., Roche Holding AG, Sanofi S.A., The Bristol-Myers Squibb Company (BMS).

Rapor, bu sektörde faaliyet gösteren şirket ve kuruluşlar için paha biçilmez bir kaynaktır. It provides a cohesive picture of the DNA repair drugs market to help drive informed decision making for industry executives, kural koyucular, akademik, ve analistler.

Rapor Kapsamı

Başvuru: breast cancer, ovarian cancer
Bölge: Asya Pasifik, Avrupa, Kuzey Amerika, Dünyanın Geri Kalanı (RoW)
Dikkate alınan yıllar: bu rapor dönemi kapsamaktadır 2018 ile 2028

Paydaşlar için Temel Faydalar

– Get a comprehensive picture of the global DNA repair drugs market
– Büyüme sektörlerini ve yatırım eğilimlerini belirleyin

İçindekiler

Parça 1. giriiş
– Çalışmanın kapsamı
– Çalışma periyodu
– Coğrafik kapsam
– Araştırma metodolojisi
Parça 2. DNA repair drugs market overview
Parça 3. Market breakdown by application
– Breast cancer
– Ovarian cancer
Parça 4. Market breakdown by region
– Asya Pasifik
– Avrupa
– Kuzey Amerika
– Dünyanın Geri Kalanı (RoW)
Parça 5. Anahtar şirketler
– Abbott Laboratories
– AbbVie Inc.
– Amgen Inc.
– AstraZeneca plc
– Bayer AG
– Eli Lilly and Company
– Gilead Sciences, A.Ş..
– GlaxoSmithKline plc (GSK)
– Johnson & Johnson
– Merck KGaA
– Novartis AG
– Pfizer Inc.
– Roche Holding AG
– Sanofi SA.
– The Bristol-Myers Squibb Company (BMS)
StratejiHelix Hakkında
Sorumluluk reddi beyanı